New insights into impact of thermal hydrolysis pretreatment temperature and time on sewage sludge: Structure and composition of sewage sludge from sewage treatment plant

Dan Xu,Xiaomin Han,Huilun Chen,Rongfang Yuan,Fei Wang,Beihai Zhou
DOI: https://doi.org/10.1016/j.envres.2020.110122
IF: 8.3
2020-12-01
Environmental Research
Abstract:<p>This work investigated the effects of THP temperature (140–200 °C) and time (10–60 min) on the surface morphology, pyrolysis properties, and soluble compounds of dewatered sludge. Results indicate that higher temperature and longer pretreatment time considerably improve organics hydrolysis (the SCOD content increased 1.4–2.46 times, increasing 2.46 times at 200 °C). In addition, high temperature also improved the sludge pyrolysis efficiency (the highest at 200 °C), and reduced the harmful gas release, especially HCN. Moreover, the surface morphology of the sludge changed, the gap and floccules on the surface of the sludge increased. The carbohydrate content increased the highest; approximately 91.9% at 170 °C. THP promoted the decomposition of the nitrogen compounds in the sludge and facilitated their transition to a liquid phase. The total nitrogen and ammonia nitrogen content doubled, and the organic nitrogen content decreased by 50% with time increased from 10 to 60 min.</p>
environmental sciences,public, environmental & occupational health
What problem does this paper attempt to address?
The paper aims to address the complex issues in anemia management for hemodialysis patients. Specifically, its goal is to evaluate the effectiveness of the Anemia Control Model (ACM) in treating anemia in hemodialysis patients. The main objective of the study is to determine whether ACM can help nephrologists make better treatment decisions, thereby improving anemia management outcomes and reducing the risks and costs associated with the use of erythropoiesis-stimulating agents (ESAs) during treatment. The study assesses the effectiveness of the model by comparing patients' hemoglobin levels, ESA usage, and anemia fluctuation when using ACM versus not using ACM. The results show that with the use of ACM, patients' hemoglobin levels are more stable, ESA usage is reduced, and secondary outcomes related to cardiovascular events, hospitalization rates, and transfusion needs are also improved. This indicates that ACM helps optimize anemia management in hemodialysis patients.